Peter Riis Hansen, MD, PhD, DMSc

Improved Clinical Outcomes with Intracoronary Compared to Intravenous Abciximab in Patients with Acute Coronary Syndromes Underg

06/03/2010

Jawdat Abdulla , MD, PhD;

Allan Zeeberg Iversen , MD, PhD;

Peter Riis Hansen , MD, PhD, DMSc;

ABSTRACT: Background. Intracoronary (IC) administration of abciximab may increase local drug levels by several orders of magnitude compared to intravenous (IV) treatment and may improve clinical outcomes in patients with acute coronary...

ABSTRACT: Background....

06/03/2010

Journal of Invasive Cardiology

Original Contribution

Impact of Abciximab in Diabetic Patients with Acute Coronary Syndrome Who Undergo Percutaneous Coronary Intervention: Results from a High-Volume, Single-Center Registry

01/01/2011

Sune Haahr-Pedersen , MD, PhD;

Rasmus Mogelvang , MD, PhD;

Jan Kyst Madsen , MD, DMSc;

Allan Zeeberg Iversen , MD, PhD;

Jan Skov Jensen , MD, PhD, DMSc;

Christian Joens , MD, PhD;

Søren Galatius , MD, DMSc;

Anders Galloe , MD, PhD;

Ulrik Abildgaard , MD, DMSc;

Peter Riis Hansen , MD, PhD, DMSc;

NULL

01/01/2011

Journal of Invasive Cardiology

Original Contribution

Long-Term Clinical Outcome in STEMI Patients Treated With Primary PCI and Drug-Eluting or Bare-Metal Stents: Insights from a High-Volume Single-Center Registry

07/28/2011

Ulla Davidsen , MD;

Sune Haahr-Pedersen , MD, PhD;

Rasmus Mogelvang , MD, PhD;

Jan Bech , MD, PhD;

Jan Kyst Madsen , MD, DMSc;

Jan Skov Jensen , MD, PhD, DMSc;

Allan Zeeberg Iversen , MD, PhD;

Søren Galatius , MD, DMSc;

Anders Galloe , MD, PhD;

Ulrik Abildgaard , MD, DMSc;

Peter Riis Hansen , MD, PhD, DMSc;

Rikke Sorensen , MD, PhD;

Steen Zabell Abildstrom , MD, PhD;

Abstract: Objective. Use of drug-eluting stents (DES) in patients with ST-elevation myocardial infarction (STEMI) during routine primary percutaneous coronary intervention (pPCI) is controversial. Methods. From January 2004 to July 2008, a...

Abstract: Objective. Use of...

07/28/2011

Journal of Invasive Cardiology